Canada orders 37 million syringes from BD in anticipation of COVID-19 vaccine

Canada reportedly signed a contract to purchase 37 million syringes from Becton Dickinson (NYSE:BDX) in preparation for a potential COVID-19 vaccine.

A report in The Record revealed that Public Services & Procurement Minister Anita Anand said the country made a purchase order from the Canadian branch of BD in an effort to make sure Canada is ready for mass vaccinations if the cure for COVID-19 is discovered. There is no definitive timeline for the delivery of the syringes as of now.

Get the full story at our sister site, MassDevice.

Read more
  • 0

Canada orders 37 million syringes from BD in anticipation of COVID-19 vaccine

Canada reportedly signed a contract to purchase 37 million syringes from Becton Dickinson (NYSE:BDX) in preparation for a potential COVID-19 vaccine.

A report in The Record revealed that Public Services & Procurement Minister Anita Anand said the country made a purchase order from the Canadian branch of BD in an effort to make sure Canada is ready for mass vaccinations if the cure for COVID-19 is discovered. There is no definitive timeline for the delivery of the syringes as of now.

Get the full story on our sister site MassDevice. 

Read more
  • 0

Canada orders 37 million syringes from BD in anticipation of COVID-19 vaccine

Canada reportedly signed a contract to purchase 37 million syringes from Becton Dickinson (NYSE:BDX) in preparation for a potential COVID-19 vaccine.

A report in The Record revealed that Public Services & Procurement Minister Anita Anand said the country made a purchase order from the Canadian branch of BD in an effort to make sure Canada is ready for mass vaccinations if the cure for COVID-19 is discovered. There is no definitive timeline for the delivery of the syringes as of now.

The Record cited Statistics Canada as reporting that more than 38 million people comprise the country’s population, one million more than the total number of syringes agreed upon in the contract. Canada Chief Public Health Officer Theresa Tam said the order represents the “maximum number of Canadians who may wish to be vaccinated,” according to the report.

Currently, Chinese pharmaceutical company CanSino Biologics is collabo…

Read more
  • 0

BD furloughs 160 employees at Nebraska plant

Becton Dickinson (NYSE:BDX) reportedly furloughed 160 employees at its Broken Bow, Neb. plant amid the COVID-19-induced dip in demand for certain healthcare products and procedures.

A report in the Sandhills Express said BD’s PR associate director of reputation management Gwen Gordon confirmed that operations will resume as soon as possible in Broken Bow, but the furlough is likely to last anywhere between four and seven weeks.

Along with the 160 employees furloughed out of nearly 600 in total, Gordon confirmed to the Sandhills Express that about 30 temporary workers at the Broken Bow facility will be released from their temporary work assignments.

Gordon told the news outlet that the furlough is a result if heightened demand for products used in diagnosing and treating COVID-19. BD’s areas of production that aren’t directly related to COVID-19 have been put on pause, resulting in the furloughs and reduced work schedules.

While B…

Read more
  • 0

Becton Dickinson prices $1.5b offerings

Becton Dickinson (NYSE:BDX) announced today that it priced offerings of common stock and depositary shares, with both set at $1.5 billion.

Franklin Lakes, N.J.-based BD’s $1.5 billion common stock offering has a par value of $1 per share at a public offering price of $2540 per share. With the $1.5 billion depositary share offering, each represents a 1/20th interest in a share of 6% mandatory convertible preferred stock at a public offering price of $50 per share.

BD also granted underwriters an option to purchase up to an additional $225 million in common stock and an additional $225 million in depositary shares, each at the public offering price, according to a news release.

The company plans to use proceeds earned from the offerings for general corporate purposes, including funding growth, working capital and repayment of outstanding indebtedness. BD expects the offerings to close on or about May 26.

Read more
  • 0